-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Coptisine chloride
Category | Influenza Virus |
CAS | 6020-18-4 |
Description | Coptisine chloride and BRB can be absorbed across intestinal epithelial cells, and they are completely absorbed compounds. |
Product Information
Synonyms | 2,3,9,10-BISMETHYLENEDIOXYPROTOBERBERINE; COPTISINE CHLORIDE; COPTISINE CHLORIDE(P); 7,8,13,13a-Tetradehydro-2,3:9,10-bis(methylenedioxy)berbinium chloride; Coptisine Hcl; Coptisine Hydrochloride; COPTISINECHLORIDE(P)(PLEASECALL); 6,7-Dihydrobis[1,3]benzodioxolo[5,6-a:4',5'-g]quinoliziniuM Chloride |
IUPAC Name | 5,7,17,19-tetraoxa-13-azoniahexacyclo[11.11.0.02,10.04,8.015,23.016,20]tetracosa-1(13),2,4(8),9,14,16(20),21,23-octaene;chloride |
Molecular Weight | 355.77 |
Molecular Formula | C19H14NO4Cl |
Canonical SMILES | C1C[N+]2=C(C=C3C=CC4=C(C3=C2)OCO4)C5=CC6=C(C=C51)OCO6.[Cl-] |
InChI | 1S/C19H14NO4.ClH/c1-2-16-19(24-10-21-16)14-8-20-4-3-12-6-17-18(23-9-22-17)7-13(12)15(20)5-11(1)14;/h1-2,5-8H,3-4,9-10H2;1H/q+1;/p-1 |
InChIKey | LUXPUVKJHVUJAV-UHFFFAOYSA-M |
Boiling Point | 601.5°C at 760 mmHg |
Melting Point | >258 °C |
Flash Point | 190.4°C |
Purity | >98% |
Density | 1.51 g/cm³ |
Solubility | Soluble in DMSO |
Appearance | Powder |
Application | anti-osteosarcoma |
Shelf Life | As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly |
Storage | Store at -20 °C |
Animal Admin | The acute toxicity of coptine was tested on Kunming mice with groups of 10 mice (half of each male and female). Coptisine is dissolved in distilled water and 8 doses (482.5, 579, 694, 833, 1,000, 1,200, 1,440 and 1,728 mg / kg) are prepared for administration. After oral administration, each mouse was observed for response, including mortality, and recorded for 1 week to obtain an LD50 value for Coptisine. To determine subchronic toxicity, the actual dose of Coptisine to SD rats (154 mg/kg/day) was obtained using the maximum HED of Coptisine (25 mg/kg) for adults (60 kg) as a reference. |
Complexity | 502 |
Exact Mass | 355.0611356 |
Index Of Refraction | 1.749 |
In Vitro | Coptisine chloride is a potent noncompetitive IDE inhibitor with a Ki value of 5.8 μM and an IC50 value of 6.3 μM. Coptisine (0.1-100 μM) inhibits the proliferation of A549, H460, H2170, MDA-MB-231, and HT-29 cells with IC50s of 18.09, 29.50, 21.60, 20.15, and 26.60 μM, respectively. Coptisine (12.5, 25, 50 μM) upregulates the expression of pH2AX and p21, reduces the expression of cyclin B1, cdc2 and cdc25C, and induces G2/M block and Apoptosis of A549 cells in a concentration-dependent manner. Coptisine (12.5, 25, 50 μM) also induces mitochondrial dysfunction and activates Caspase activity in A549 cells. Furthermore, Coptisine (50 μM) increases ROS levels in a time-dependent manner (0.5, 1, 2, 4, 12, and 24 hours). |
In Vivo | Coptisine showed increased toxicity in mice in a concentration-dependent manner with an LD50 value of 880.18 mg/kg. Cyclopsin (154 mg/kg/day, 90 days) is not toxic to SD rats. Coptisine (23.35, 46.7, 70.05 mg/kg, po) dose-dependently reduces TC, TG and LDL-c levels and increases HDL-c content in hamster serum to varying degrees, slows HFHC-induced weight gain diet, and dose-dependently raises levels of cholesterol and TBA in feces. Coptisine (70.05 mg/kg, po) inhibits HMGCR protein expression levels and induces protein expression of SREBP-2, LDLR, and CYP7A1 involved in cholesterol metabolism. |
PSA | 4.8 |
Target | Indoleamine 2,3-Dioxygenase (IDO); Bacterial; Influenza Virus |